Fasting and Breast Cancer Treatment Study
Part of Cancer, Skin clinical trials.
This study looks at whether periods of fasting (eating for shorter time windows) might help improve how well a breast cancer medication called capivasertib works. You'll wear a glucose monitor, track your food, and follow fasting schedules while continuing your regular cancer treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and have metastatic breast cancer (cancer that has spread beyond the breast)
- You are currently taking capivasertib (a targeted cancer drug) and have been stable on it for at least 2 weeks
- You are either post-menopausal or taking medication to suppress your ovaries
- Your BMI is 25 or higher (a measure based on height and weight)
- You have good overall health status (able to do light activities; ECOG score 0–1)
- You can use a smartphone or tablet, wear a glucose monitor continuously, track meals in an app, and follow fasting instructions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether a 14-hour night fast and 10-hour eating window can improve inflammation markers and quality of life in women with HR+/HER2- early breast cancer. You would start the fasting routine within three months of beginning hormone therapy.
This study tests if a special diet that mimics fasting can help reduce side effects from hormone therapy (aromatase inhibitors) in women with breast cancer. The diet is a low-calorie meal plan designed to lower cholesterol and improve well-being.
This study looks at whether fasting overnight and/or doing exercise can help improve fatigue and other quality-of-life measures in women with advanced hormone receptor positive breast cancer who are already taking a CDK4/6 inhibitor. Participation may involve following a fasting or exercise plan for a period of time.
This trial tests whether short-term fasting before chemotherapy is better than eating freely for women with advanced ovarian cancer. It aims to see if fasting can help treatment work better or reduce side effects.
This trial studies whether intermittent fasting (eating only during certain hours) can make immunotherapy treatment work better or cause fewer side effects in people with certain advanced cancers. If you can safely fast, this could be a way to boost your treatment.
This trial adds a fasting-mimicking diet to standard chemotherapy before surgery for a specific type of breast cancer. The diet may help make the chemotherapy work better while reducing side effects.
Hear when a new Metastatic Breast Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.